Why the study?
It remains unclear whether pregnant patients carrying a fetus with congenital heart defects require special care or modifications to regular maternal supplementation.
Does supplementation with folic acid and vitamin D improve outcomes in pregnant women with foetal cardiac diseases?
Does supplementation with folic acid and vitamin D improve outcomes in pregnant women with foetal cardiac diseases?
Answers are grounded in this paper and cite their sources.
This report proposes rich supplementation with folic acid and vitamin D for pregnant women with fetal cardiac diseases to improve postnatal prognosis and prevent complications like pre-eclampsia.
Should we pay special attention to the supplementation for patients with a congenital foetal heart defect, whether they require special care, assuming that each subsequent pregnancy should be planned? Should patients with cardiac problems in their current pregnancy make any changes to their regular supplementation? In our short report we would like to discuss the issues of supplementation, especially folates and vitamin D, from the perspective of prenatal cardiology and specific problems affecting postnatal prognosis, paying special attention to the prevention of COVID-19 and pre-eclampsia during pregnancy. We propose that our observations be considered concerning mainly rich supplementation with folic acid as well as vitamin D for patients with cardiac problems in the foetus.
No takes yet. Share an insight, caveat, or question.
Murlewska et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: